Addressing Tandem MS in Newborn Screening

ASHG and the American College of Medical Genetics issued a 2000 statement describing tandem mass spectrometry and its potential role in newborn screening programs. The statement describes the state of the science as well as questions to be considered in its implementation, including funding and training.


ASHG uses cookies to provide you with a secure and custom web experience. Privacy Policy